Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer

NCT00217399 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

35

Enrollment

NIH

Sponsor class

Conditions

Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions

DRUG: sorafenib tosylate
DRUG: anastrozole

Sponsor

National Cancer Institute (NCI)